Log in to save to my catalogue

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of EC...

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of EC...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754868626

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

About this item

Full title

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2010-05, Vol.375 (9727), p.1695-1703

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Early administration of intravenous recombinant tissue plasminogen activator (rt-PA) after ischaemic stroke improves outcome. Previous analysis of combined data from individual patients suggested potential benefit beyond 3 h from stroke onset. We re-examined the effect of time to treatment with intravenous rt-PA (alteplase) on th...

Alternative Titles

Full title

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_754868626

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754868626

Other Identifiers

ISSN

0140-6736,1474-547X

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(10)60491-6

How to access this item